Akèy › Fibroz Pulmonè Idyopatik › Texas
Etid klinik pou Fibroz Pulmonè Idyopatik nan Texas
11 etid pou Fibroz Pulmonè Idyopatik ap chèche patisipan nan sit nan Texas.
Vil nan Texas
Tèks ofisyèl etid la (Anglè)
An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL)
- El Paso Pulmonary Association, P.A., El Paso
- Baylor College of Medicine, Houston
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT06951217A Phase IIb Study to Evaluate AZD8965 in Participants With IPF.
- Research Site, Dallas
- Research Site, El Paso
- Research Site, Houston
Ap rekriteFaz 2
Laj 40 ak plis · Tout sèks · Mizajou Sep 21, 2026 · NCT07652658A Study to Find an Efficacious and Safe Dose of CHF10067 (Zampilimab) in Participants With Idiopathic Pulmonary Fibrosis
- Premier Pulmonary Critical Care and Sleep Medicine, PA, Denison
Ap rekriteFaz 2
Laj 40 ak plis · Tout sèks · Mizajou Sep 17, 2026 · NCT07516951RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
- Dell Medical School, University of Texas at Austin, Austin
Ap rekriteFaz 2
Laj 18 a 80 · Tout sèks · Mizajou Sep 15, 2026 · NCT07002034Idiopathic Pulmonary Fibrosis (IPF)-Related Chronic Cough Reduction With Nalbuphine Extended-Release (NAL ER) Tablets
- Horizon Clinical Research Group, Cypress
- El Paso Pulmonary Association, PA, El Paso
- Elevate Clinical Research, Houston
Ap rekriteFaz 3
Laj 40 ak plis · Tout sèks · Mizajou Sep 14, 2026 · NCT07671911A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis
- El Paso Pulmonary Association, El Paso
- Baylor College of Medicine, Houston
- Baylor Scott and White Health, Temple
Ap rekriteFaz 2
Laj 40 ak plis · Tout sèks · Mizajou Sep 4, 2026 · NCT06968845Trial to Evaluate the Efficacy and Safety of LYT-100 (Deupirfenidone) Compared to Pirfenidone in Adults With Idiopathic Pulmonary Fibrosis (IPF)
- Premier Pulmonary Critical Care and Sleep Medicine, Denison
- Renovatio Clinical, The Woodlands
- Renovatio Clinical, Webster
Ap rekriteFaz 3
Laj 40 ak plis · Tout sèks · Mizajou Sep 3, 2026 · NCT07284602Oral Ifetroban in Patients With Idiopathic Pulmonary Fibrosis (IPF)
- Baylor University Medical Center, Dallas
- Premier Pulmonary Critical Care and Sleep Medicine, Denison
Ap rekriteFaz 2
Laj 40 ak plis · Tout sèks · Mizajou Sep 2, 2026 · NCT05571059Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
- University of Texas Southwestern, Dallas
- Baylor University Medical Center at Dallas, Dallas
- Baylor College of Medicine, Houston
- ak 2 plis
Ap rekriteEtid obsèvasyon
Laj 21 ak plis · Tout sèks · Mizajou Aug 12, 2026 · NCT01915511WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)
- WISPer site in Dallas, TX, Dallas
Ap rekriteFaz 2
Laj 40 ak plis · Tout sèks · Mizajou Aug 10, 2026 · NCT06967805Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis
- University of Texas Southwestern Medical Center, Dallas
- Metroplex Pulmonary and Sleep Center, McKinney
- Research Centers of America, McKinney
Ap rekriteFaz 2
Laj 40 ak plis · Tout sèks · Mizajou Nov 12, 2025 · NCT05975983Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.